Clinical Trial Update: A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada

View source ↗

Summary

A completed clinical trial evaluating Cytomegalovirus infection outcomes among solid organ transplant recipients in Europe and Canada. The sponsor is Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: Takeda | Conditions: Cytomegalovirus (CMV) | Status: COMPLETED